Related references
Note: Only part of the references are listed.Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet et al.
ALLERGY (2008)
Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production
Sarnuele E. Burastero et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)
Global strategy for asthma management and prevention: GINA executive summary
E. D. Bateman et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy
J. Savolainen et al.
ALLERGY (2007)
Allergen immunotherapy: Where is it now?
Harold S. Nelson
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC
J. Savolainen et al.
ALLERGY (2006)
Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10-production
L Cosmi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children
E Dehlink et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy
F Marcucci et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2005)
Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report
G Ciprandi et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy
S Rak et al.
ALLERGY (2005)
A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma
RE Rossi et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)
Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen
C Rolinck-Werninghaus et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis
RE Rossi et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers
M Bagnasco et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)
Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy
C Arikan et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study
MS Khinchi et al.
ALLERGY (2004)
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
M Akdis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis
E Novembre et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Noninjection routes for immunotherapy
GW Canonica et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Allergic rhinitis and its impact on asthma
J Bousquet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)